Adam Scott Levy, the CFO and Secretary of $MLYS, sold 8,425 shares of the company on 07-30-2025 for an estimated $127,203. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.0% of their shares of this class of stock. Following this trade, they now own 132,934 shares of this class of $MLYS stock.
$MLYS Insider Trading Activity
$MLYS insiders have traded $MLYS stock on the open market 20 times in the past 6 months. Of those trades, 4 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $MLYS stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, L.P. RA purchased 1,296,296 shares for an estimated $17,499,996
- SRINIVAS AKKARAJU purchased 600,000 shares for an estimated $8,100,000
- BIOCAPITAL GP, LLC SAMSARA purchased 600,000 shares for an estimated $8,100,000
- BRIAN TAYLOR SLINGSBY purchased 259,259 shares for an estimated $3,499,996
- DAVID MALCOM RODMAN (Chief Medical Officer) has made 0 purchases and 8 sales selling 101,235 shares for an estimated $1,549,777.
- ADAM SCOTT LEVY (CFO and Secretary) has made 0 purchases and 6 sales selling 95,193 shares for an estimated $1,362,615.
- JON CONGLETON (Chief Executive Officer) has made 0 purchases and 2 sales selling 31,203 shares for an estimated $417,233.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MLYS Hedge Fund Activity
We have seen 103 institutional investors add shares of $MLYS stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUVRETTA CAPITAL MANAGEMENT, LLC added 1,667,759 shares (+inf%) to their portfolio in Q1 2025, for an estimated $26,484,012
- ORBIMED ADVISORS LLC removed 1,611,637 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $25,592,795
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC added 1,425,000 shares (+162.9%) to their portfolio in Q1 2025, for an estimated $22,629,000
- RA CAPITAL MANAGEMENT, L.P. added 1,296,296 shares (+26.7%) to their portfolio in Q1 2025, for an estimated $20,585,180
- PICTET ASSET MANAGEMENT HOLDING SA added 1,214,373 shares (+inf%) to their portfolio in Q1 2025, for an estimated $19,284,243
- CALIGAN PARTNERS LP added 1,138,512 shares (+112.6%) to their portfolio in Q1 2025, for an estimated $18,079,570
- ADAMS STREET PARTNERS LLC removed 1,129,807 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,941,335
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MLYS Analyst Ratings
Wall Street analysts have issued reports on $MLYS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/17/2025
- Guggenheim issued a "Buy" rating on 02/24/2025
- Goldman Sachs issued a "Buy" rating on 02/13/2025
To track analyst ratings and price targets for $MLYS, check out Quiver Quantitative's $MLYS forecast page.
$MLYS Price Targets
Multiple analysts have issued price targets for $MLYS recently. We have seen 3 analysts offer price targets for $MLYS in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Matthew Caufield from HC Wainwright & Co. set a target price of $42.0 on 06/17/2025
- Dennis Ding from Jefferies set a target price of $15.0 on 06/11/2025
- Richard Law from Goldman Sachs set a target price of $24.0 on 02/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
